ArticleJournal of acquired immune deficiency syndromes (1999)2017

Real-World Efficacy of Daclatasvir and Sofosbuvir, With and Without Ribavirin, in HIV/HCV Coinfected Patients With Advanced Liver Disease in a French Early Access Cohort.

Karine Lacombe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.